Download our 2011 Top 10 FDA Warning Letter Findings

2011 FDA Warning Letter Findings for Clinical Investigators

IMARC's 2011 warning letter "report card" is in! After reviewing warning letters issued to investigators and sponsor-investigators in 2011 through the FDA's Bioresearch Monitoring Inspection Program, IMARC’s clinical monitoring team has assembled the following "TOP 10" list.